Abiopharma

News list

📋 GUGGENHIME ANDREW (Officer) plans to sell 10K shares of Vaxcyte, Inc. (at $53.99 each, total $540K) Filed: Aug 03, 2026 | ID: 000830

Full text

News bot Aug. 3, 2026, 8:17 p.m.
📋 Form 144 Filing: GUGGENHIME ANDREW

Company: Vaxcyte, Inc.

Filing Date: 2026-08-03

Relationship: Officer
Planned Sale Details:
- Security: Common
- Shares to be Sold: 10,000
- Price per Share: $53.99
- Total Value: $539,900.00
- Planned Sale Date: 2026-08-03
- Broker: UBS Financial Services, Inc
- Exchange: NASDAQ
Additional Information:
- SEC File Number: 001-39323
- Issuer Contact Phone: 650-837-0111
- Issuer Address: 825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA, 94070
- Broker Address: 11 Madison Ave, 4th Floor, New York, NY, 10010
- Shares Outstanding: 144397682.0
- Number of Securities to be Sold: 1
- Number of Past Sales: 2
- Signature: /s/ UBS Financial Services, Inc. as attorney-in-fact for Andrew Guggenhime